Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A

Experimental Cell Research

Volumn 312, Issue 8, 2006, Pages 1371-1380

  Olsen, Hanne ^a   Haldosén, Lars Arne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Mammary epithelial cells; MAPK; PPAR ; STAT5A

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; EPIDERMAL GROWTH FACTOR; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; STAT5A PROTEIN; TROGLITAZONE;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENETIC TRANSFECTION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 33646023980     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.12.023     Document Type: Article

References (48)

1. Palmer C.N., Hsu M.H., Griffin H.J., and Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270 (1995) 16114-16121
2. Hihi A.K., Michalik L., and Wahli W. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59 (2002) 790-798
3. Yee L.D., Sabourin C.L., Liu L., Li H.M., Smith P.J., Seewaldt V., and Kniss D.A. Peroxisome proliferator-activated receptor gamma activation in human breast cancer. Int. J. Oncol. 15 (1999) 967-973
4. Yee L.D., Guo Y., Bradbury J., Suster S., Clinton S.K., and Seewaldt V.L. The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells. Breast Cancer Res. Treat 78 (2003) 179-192
5. Mueller E., Sarraf P., Tontonoz P., Evans R.M., Martin K.J., Zhang M., Fletcher C., Singer S., and Spiegelman B.M. Terminal differentiation of human breast cancer through PPAR gamma. Mol. Cell 1 (1998) 465-470
6. Kelly P.A., Bachelot A., Kedzia C., Hennighausen L., Ormandy C.J., Kopchick J.J., and Binart N. The role of prolactin and growth hormone in mammary gland development. Mol. Cell. Endocrinol. 197 (2002) 127-131
7. Silberstein G.B. Postnatal mammary gland morphogenesis. Microsc. Res. Tech. 52 (2001) 155-162
8. Hennighausen L., and Robinson G.W. Signaling pathways in mammary gland development. Dev. Cell 1 (2001) 467-475
9. Rosen J.M., Wyszomierski S.L., and Hadsell D. Regulation of milk protein gene expression. Annu. Rev. Nutr. 19 (1999) 407-436
10. Groner B. Transcription factor regulation in mammary epithelial cells. Domest. Anim. Endocrinol. 23 (2002) 25-32
11. Wakao H., Gouilleux F., and Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13 (1994) 2182-2191 (published erratum appears in EMBO J. 1995 Feb 15;14(4):854-855)
12. Mui A.L., Wakao H., O'Farrel A.M., Harada N., and Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 14 (1995) 1166-1175
13. Liu X., Robinson G.W., Gouilleux F., Groner B., and Hennighausen L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8831-8835
14. Liu X., Robinson G.W., and Hennighausen L. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol. 10 (1996) 1496-1506
15. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A., and Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11 (1997) 179-186
16. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., and Davey H.W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7239-7244
17. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., and Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 (1998) 841-850
18. Stephens J.M., Morrison R.F., and Pilch P.F. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J. Biol. Chem. 271 (1996) 10441-10444
19. Harp J.B., Franklin D., Vanderpuije A.A., and Gimble J.M. Differential expression of signal transducers and activators of transcription during human adipogenesis. Biochem. Biophys. Res. Commun. 281 (2001) 907-912
20. Nanbu-Wakao R., Morikawa Y., Matsumura I., Masuho Y., Muramatsu M.A., Senba E., and Wakao H. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Mol. Endocrinol. 16 (2002) 1565-1576
21. Shang C.A., and Waters M.J. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol. Endocrinol. 17 (2003) 2494-2508
22. Floyd Z.E., and Stephens J.M. STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes 52 (2003) 308-314
23. Stephens J.M., Morrison R.F., Wu Z., and Farmer S.R. PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis. Biochem. Biophys. Res. Commun. 262 (1999) 216-222
24. Ball R.K., Friis R.R., Schoenenberger C.A., Doppler W., and Groner B. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7 (1988) 2089-2095
25. Doppler W., Groner B., and Ball R.K. Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 104-108
26. Petersen H., and Haldosen L.A. EGF modulates expression of STAT5 in mammary epithelial cells. Exp. Cell Res. 243 (1998) 347-358
27. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
28. Shi W., Inoue M., Minami M., Takeda K., Matsumoto M., Matsuda Y., Kishimoto T., and Akira S. The genomic structure and chromosomal localization of the mouse STAT3 gene. Int. Immunol. 8 (1996) 1205-1211
29. Yan R., Qureshi S., Zhong Z., Wen Z., and Darnell Jr. J.E. The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2. Nucleic Acids Res. 23 (1995) 459-463
30. Crispi S., Sanzari E., Monfregola J., De Felice N., Fimiani G., Ambrosio R., D'Urso M., and Ursini M.V. Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation. FEBS Lett. 562 (2004) 27-34
31. Camp H.S., Tafuri S.R., and Leff T. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity. Endocrinology 140 (1999) 392-397
32. Gimble J.M., Pighetti G.M., Lerner M.R., Wu X., Lightfoot S.A., Brackett D.J., Darcy K., and Hollingsworth A.B. Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands. Biochem. Biophys. Res. Commun. 253 (1998) 813-817
33. Cui Y., Miyoshi K., Claudio E., Siebenlist U.K., Gonzalez F.J., Flaws J., Wagner K.U., and Hennighausen L. Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J. Biol. Chem. 277 (2002) 17830-17835
34. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 (1992) 771-774
35. Issemann I., Prince R.A., Tugwood J.D., and Green S. The peroxisome proliferator-activated receptor:retinoid×receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11 (1993) 37-47
36. Willson T.M., Cobb J.E., Cowan D.J., Wiethe R.W., Correa I.D., Prakash S.R., Beck K.D., Moore L.B., Kliewer S.A., and Lehmann J.M. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39 (1996) 665-668
37. Adams M., Reginato M.J., Shao D., Lazar M.A., and Chatterjee V.K. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272 (1997) 5128-5132
38. Camp H.S., and Tafuri S.R. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272 (1997) 10811-10816
39. Yang Z., Bagheri-Yarmand R., Balasenthil S., Hortobagyi G., Sahin A.A., Barnes C.J., and Kumar R. HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy. Clin. Cancer Res. 9 (2003) 3198-3203
40. Prusty D., Park B.H., Davis K.E., and Farmer S.R. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 277 (2002) 46226-46232
41. Robinson G.W., Johnson P.F., Hennighausen L., and Sterneck E. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev. 12 (1998) 1907-1916
42. Sarraf P., Mueller E., Jones D., King F.J., DeAngelo D.J., Partridge J.B., Holden S.A., Chen L.B., Singer S., Fletcher C., and Spiegelman B.M. Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat. Med. 4 (1998) 1046-1052
43. Chang T.H., and Szabo E. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Res. 60 (2000) 1129-1138
44. Badawi A.F., and Badr M.Z. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma. Int. J. Oncol. 20 (2002) 1109-1122 (Review)
45. Suh N., Wang Y., Williams C.R., Risingsong R., Gilmer T., Willson T.M., and Sporn M.B. A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. Cancer Res. 59 (1999) 5671-5673
46. Liu H., Zang C., Fenner M.H., Possinger K., and Elstner E. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res. Treat. 79 (2003) 63-74
47. Clegg R.A., Barber M.C., Pooley L., Ernens I., Larondelle Y., and Travers M.T. Milk fat synthesis and secretion: molecular and cellular aspects. Livest. Prod. Sci. 70 (2000) 3-14
48. Mao J., Molenaar A.J., Wheeler T.T., and Seyfert H.M. STAT5 binding contributes to lactational stimulation of promoter III expressing the bovine acetyl-CoA carboxylase alpha-encoding gene in the mammary gland. J. Mol. Endocrinol. 29 (2002) 73-88